Adrenalectomy Versus Follow-up in Patients With Subclinical Cushings Syndrome (AUSC)
Adrenalectomy Versus Follow-up in Patients With Mild Hypercortisolism: a Prospective Randomized Controlled Trial
Sponsor: Region Skane
Terminated
Slow recruitment
Listed as NCT01246739, this NA trial focuses on Adrenal Tumour With Mild Hypercortisolism and remains terminated or withdrawn. Sponsored by Region Skane, it has been updated 14 times since 2011, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
14 versions recorded-
Sep 2025 — Present [monthly]
Terminated NA
-
Sep 2024 — Sep 2025 [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
May 2024 — Jul 2024 [monthly]
Terminated NA
Status: Active Not Recruiting → Terminated
-
May 2023 — May 2024 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
▶ Show 9 earlier versions
-
Feb 2023 — May 2023 [monthly]
Recruiting NA
-
Feb 2022 — Feb 2023 [monthly]
Recruiting NA
-
Oct 2021 — Feb 2022 [monthly]
Recruiting NA
-
Jan 2021 — Oct 2021 [monthly]
Recruiting NA
-
May 2020 — Jan 2021 [monthly]
Recruiting NA
-
Apr 2019 — May 2020 [monthly]
Recruiting NA
-
Jun 2018 — Apr 2019 [monthly]
Recruiting NA
-
Feb 2018 — Jun 2018 [monthly]
Recruiting NA
-
Jan 2017 — Feb 2018 [monthly]
Recruiting NA
First recorded
Jun 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Region Skane
For direct contact, visit the study record on ClinicalTrials.gov .